Market Tracker

07/01 7:40am ET

Sarepta Therapeutics Inc (NASDAQ:SRPT)

19.07
Delayed Data
As of Jun 30
 +0.41 / +2.20%
Today’s Change
8.00
Today|||52-Week Range
41.97
-50.57%
Year-to-Date
141 Reasons to Love Biotech Stocks
Jun 30 / MotleyFool.com - Paid Partner Content
Fake Tweets Sink Stocks: What Happens When Scammers Impersonate Research Firms
Jun 21 / MotleyFool.com - Paid Partner Content
3 Tempting Stocks to Avoid
Jun 26 / MotleyFool.com - Paid Partner Content
Stocks: 4 things to know before the open
Jun 07 / CNNMoney.com

Today’s Trading

Previous close18.66
Today’s open18.56
Day’s range18.29 - 19.30
Volume2,206,182
Average volume (3 months)6,051,812
Market cap$894.3M
Dividend yield--
Data as of 06/30/2016

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+9.94%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book4.47

Competitors

 Today’s
change
Today’s
% change
INSYINSYS Therapeutics I...+0.42+3.35%
RGENRepligen Corp+0.73+2.74%
LCILannett Company Inc+0.13+0.55%
FWPForward Pharma A/S-0.19-1.03%
Data as of 06/30/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Senior VP, Chief Executive &
Medical Officer
Edward M. Kaye
Head-Operations &
Vice President
Gavin T. Malenfant
Corporate headquarters
Cambridge, Massachusetts

Forecasts